Enhanced survival for patients with hepatocellular carcinoma
A new study has unveiled a promising adjuvant therapy regimen that significantly improves patient outcomes…
Browsing: Featured
Study finds anti-H. pylori treatment associated with improved survival in gastric cancer
Gastric cancer (GC) remains a significant global health concern despite recent declines in incidence. It…
Episode 9: Understanding and Managing Chemotherapy-Induced Peripheral Neuropathy
Welcome to the ninth episode of Supportive Care Matters, a podcast Hosted by Medical Oncologist Professor Bogda Koczwara AM from Adelaide, Australia.
Navigating the silent struggle that many cancer survivors face, this episode promises insights into the lesser-known yet impactful world of chemotherapy-induced peripheral neuropathy (CIPN). With the expertise of Professor David Goldstein and Associate Professor Susanna Park, this episode sheds light on how CIPN disrupts daily life in ways that go unnoticed by the medical community.
Coffee reduces mortality in people with intestinal cancer
Recent research published in the International Journal of Cancer indicates that individuals who have previously…
Olaparib and durvalumab demonstrated strong clinical benefit in mismatch repair proficient advanced or recurrent endometrial cancer
Latest analysis of the results from the DUO-E Phase III trial showed durvalumab plus platinum-based…
New treatment option for prostate cancer shows successful outcomes
A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is…
Cryoablation highly effective for breast cancer patients with large tumours
A minimally invasive technique that uses ice to freeze and destroy small, cancerous tumours has…
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies
Researchers have developed a genetic test that can identify how patients with triple negative early-stage…
New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug,…
‘3D mammography’ almost halves the incidence of breast cancer between two screening tests
Interval breast cancer is one that appears between two reviews of a screening program. That…